日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolution of altered tubular metabolism and mitochondrial function in sepsis-associated acute kidney injury

脓毒症相关急性肾损伤中肾小管代谢和线粒体功能改变的演变

Ying Li, Noureddin Nourbakhsh, Hai Pham, Rick Tham, Jonathan E Zuckerman, Prabhleen Singh

Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca2+ entry in glomerular mesangial cells

肾小球系膜细胞中钙池操纵的 Ca2+ 内流对 Smad1 通路和 IV 型胶原蛋白表达的负向调节

Peiwen Wu, Yuezhong Ren, Yuhong Ma, Yanxia Wang, Hui Jiang, Sarika Chaudhari, Mark E Davis, Jonathan E Zuckerman, Rong Ma

Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells

钙池操纵的钙内流抑制肾小球系膜细胞中的 TGF-β1/Smad3 信号通路

Sarika Chaudhari, Weizu Li, Yanxia Wang, Hui Jiang, Yuhong Ma, Mark E Davis, Jonathan E Zuckerman, Rong Ma

CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing

静脉注射后,CRLX101 纳米粒子定位于人类肿瘤中,而不是邻近的非肿瘤组织中

Andrew J Clark, Devin T Wiley, Jonathan E Zuckerman, Paul Webster, Joseph Chao, James Lin, Yun Yen, Mark E Davis

siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA

使用含有 siRNA 的多聚阳离子环糊精纳米粒子将 siRNA 递送至肾小球系膜细胞

Jonathan E Zuckerman, Aaron Gale, Peiwen Wu, Rong Ma, Mark E Davis

Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle

多功能聚合物纳米颗粒的临床前动物研究与人体临床试验的关联

Scott Eliasof, Douglas Lazarus, Christian G Peters, Roy I Case, Roderic O Cole, Jungyeon Hwang, Thomas Schluep, Joseph Chao, James Lin, Yun Yen, Han Han, Devin T Wiley, Jonathan E Zuckerman, Mark E Davis

Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth

系统性递送针对 RRM2 的 siRNA 纳米粒子可抑制头颈部肿瘤的生长

Mohammad Aminur Rahman, A R M Ruhul Amin, Xu Wang, Jonathan E Zuckerman, Chung Hang J Choi, Bingsen Zhou, Dongsheng Wang, Sreenivas Nannapaneni, Lydia Koenig, Zhengjia Chen, Zhuo Georgia Chen, Yun Yen, Mark E Davis, Dong M Shin